# Place of the Hevylite Test in the Evaluation of MRD in Myeloma

> **NCT03702088** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 124 (estimated)

## Conditions studied

- Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03702088
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-30
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2019-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702088, "Place of the Hevylite Test in the Evaluation of MRD in Myeloma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03702088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*